Milrinone Versus Placebo in Patients With Septic Shock
Condition(s):Septic Shock; Cardiac OutputLast Updated:September 15, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Septic Shock; Cardiac OutputLast Updated:September 15, 2022Recruiting
Condition(s):Ischemic Heart Disease; Valvular Heart DiseaseLast Updated:January 19, 2024Recruiting
Condition(s):Pulmonary Hypertension Due to Left Heart DiseaseLast Updated:January 4, 2023Recruiting
Condition(s):Persistent Pulmonary HypertensionLast Updated:May 18, 2020Completed
Condition(s):Mitral Valve Replacement; Pulmonary Hypertension; Inhaled Milrinone; Intravenous MilrinoneLast Updated:March 13, 2024Active, not recruiting
Condition(s):Ischemic Heart DiseaseLast Updated:September 28, 2023Not yet recruiting
Condition(s):VasospasmLast Updated:November 3, 2022Recruiting
Condition(s):Pulmonary HypertensionLast Updated:November 14, 2012Completed
Condition(s):Low Cardiac Output Syndrome; Cardiac Surgical Procedures; InfantLast Updated:January 30, 2019Unknown status
Condition(s):Persistent Fetal Circulation SyndromeLast Updated:July 12, 2016Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.